Viewing Study NCT00123461


Ignite Creation Date: 2025-12-24 @ 1:04 PM
Ignite Modification Date: 2026-06-01 @ 12:34 AM
Study NCT ID: NCT00123461
Status: COMPLETED
Last Update Posted: 2015-05-05
First Post: 2005-07-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism
Sponsor: Genzyme, a Sanofi Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Secondary Hyperparathyroidism View
None Renal Failure View
None Chronic Renal Insufficiency View
Keywords: